Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Targeting nano-regulator based on metal–organic frameworks for enhanced immunotherapy of bone metastatic prostate cancer

Fig. 4

A The dynamic monitoring of body weight of mice during various treatments. B, C The quantification of various representative biochemical indexes in serum after various treatment. D The H&E staining of major organs from mice after different treatments. Scale bar = 25 μm. For each group, (1) control; (2) αCTLA-4; (3) MTO@PA/Fe3+ MOF; (4) MTO@PA/Fe3+ MOF plus αCTLA-4

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us